Companies / Plus Therapeutics, Inc. / Activity
Activity — Plus Therapeutics, Inc.
11 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q3 2024 as of | Danske Bank A/S 13F manager | New | Common stock | $1 | +1 | 1 <0.01% of shares | low |
| Q3 2025 as of | Barclays PLC 13F manager | Trim | Common stock | $-50 | -100 -98.04% | 2 <0.01% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common stock | $222 | +434 +52.23% | 1,265 0.02% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | Trim | Common stock | $-331 | -937 -90.18% | 102 <0.01% of shares | low |
| Q1 2025 as of | Barclays PLC 13F manager | New | Common stock | $987 | +1K | 1,039 0.02% of shares | low |
| Q1 2026 as of | Royal Bank of Canada 13F manager | Exit | Common stock | $-1.0K | -1K -100.00% | 0 | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | New | Common stock | $44.2K | +272K | 271,599 3.95% of shares | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common stock | $99.8K | +614K +43.74% | 2,016,314 29.29% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | Exit | Common stock | $-240.2K | -469K -100.00% | 0 | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | New | Common stock | $419.4K | +96K | 95,983 1.39% of shares | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Exit | Common stock | $-910.0K | -1.8M -100.00% | 0 | low |